Northern Trust
IMGN

Northern Trust’s Immunogen Inc IMGN Stock Holding History

Northern Trust’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,328,671
Closed -$69M – 4534
2023
Q4 		$69M Sell
2,328,671
-42,193
-2% -$840K 0.01% 798
2023
Q3 		$37.6M Sell
2,370,864
-25,182
-1% -$419K 0.01% 1123
2023
Q2 		$45.2M Buy
2,396,046
+252,225
+12% +$2.98M 0.01% 1041
2023
Q1 		$8.23M Sell
2,143,821
-4,715
-0.2% -$20.1K ﹤0.01% 2150
2022
Q4 		$10.7M Buy
2,148,536
+21,682
+1% +$118K ﹤0.01% 1961
2022
Q3 		$10.2M Sell
2,126,854
-17,276
-0.8% -$91.1K ﹤0.01% 1959
2022
Q2 		$9.65M Sell
2,144,130
-54,108
-2% -$235K ﹤0.01% 2059
2022
Q1 		$10.5M Buy
2,198,238
+68,730
+3% +$381K ﹤0.01% 2117
2021
Q4 		$15.8M Buy
2,129,508
+21,104
+1% +$131K ﹤0.01% 1941
2021
Q3 		$12M Sell
2,108,404
-23,962
-1% -$138K ﹤0.01% 2151
2021
Q2 		$14.1M Buy
2,132,366
+35,574
+2% +$248K ﹤0.01% 2133
2021
Q1 		$17M Sell
2,096,792
-21,483
-1% -$175K ﹤0.01% 1949
2020
Q4 		$13.7M Buy
2,118,275
+59,250
+3% +$346K ﹤0.01% 2053
2020
Q3 		$7.41M Sell
2,059,025
-92,275
-4% -$373K ﹤0.01% 2286
2020
Q2 		$9.9M Buy
2,151,300
+33,796
+2% +$144K ﹤0.01% 2102
2020
Q1 		$7.22M Buy
2,117,504
+327,023
+18% +$1.43M ﹤0.01% 2094
2019
Q4 		$9.14M Sell
1,790,481
-77,510
-4% -$263K ﹤0.01% 2232
2019
Q3 		$4.52M Buy
1,867,991
+100,017
+6% +$266K ﹤0.01% 2607
2019
Q2 		$3.84M Sell
1,767,974
-1,152
-0.1% -$2.72K ﹤0.01% 2695
2019
Q1 		$4.79M Sell
1,769,126
-4,647
-0.3% -$20.1K ﹤0.01% 2589
2018
Q4 		$8.51M Sell
1,773,773
-21,154
-1% -$128K ﹤0.01% 2190
2018
Q3 		$17M Buy
1,794,927
+202,760
+13% +$1.95M ﹤0.01% 1923
2018
Q2 		$15.5M Buy
1,592,167
+367,337
+30% +$3.87M ﹤0.01% 1963
2018
Q1 		$12.9M Buy
1,224,830
+15,530
+1% +$153K ﹤0.01% 1994
2017
Q4 		$7.75M Buy
1,209,300
+149,181
+14% +$920K ﹤0.01% 2349
2017
Q3 		$8.11M Buy
1,060,119
+9,739
+0.9% +$64.7K ﹤0.01% 2328
2017
Q2 		$7.47M Sell
1,050,380
-18,440
-2% -$84.4K ﹤0.01% 2358
2017
Q1 		$4.14M Buy
1,068,820
+50,576
+5% +$148K ﹤0.01% 2674
2016
Q4 		$2.08M Buy
1,018,244
+10,090
+1% +$20.3K ﹤0.01% 3070
2016
Q3 		$2.7M Sell
1,008,154
-2,150
-0.2% -$6.25K ﹤0.01% 2907
2016
Q2 		$3.11M Sell
1,010,304
-26,699
-3% -$167K ﹤0.01% 2781
2016
Q1 		$8.84M Buy
1,037,003
+19,867
+2% +$168K ﹤0.01% 2060
2015
Q4 		$13.8M Buy
1,017,136
+26,931
+3% +$331K ﹤0.01% 1767
2015
Q3 		$9.51M Sell
990,205
-4,039
-0.4% -$59K ﹤0.01% 2025
2015
Q2 		$14.3M Buy
994,244
+21,729
+2% +$239K ﹤0.01% 1829
2015
Q1 		$8.7M Buy
972,515
+4,254
+0.4% +$30.8K ﹤0.01% 2155
2014
Q4 		$5.91M Sell
968,261
-32,460
-3% -$297K ﹤0.01% 2397
2014
Q3 		$10.6M Buy
1,000,721
+3,007
+0.3% +$34K ﹤0.01% 2000
2014
Q2 		$11.8M Sell
997,714
-161,008
-14% -$2.02M ﹤0.01% 1911
2014
Q1 		$17.3M Sell
1,158,722
-67,961
-6% -$1.07M 0.01% 1695
2013
Q4 		$18M Buy
1,226,683
+23,656
+2% +$364K 0.01% 1615
2013
Q3 		$20.5M Sell
1,203,027
-7,727
-0.6% -$136K 0.01% 1439
2013
Q2 		$20.1M Buy
+1,210,754
New +$19.6M 0.01% 1378

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Northern Trust's IMGN Position: Q1 2024 in Review

Northern Trust sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 2,328,671 shares — an estimated $69M sold.

Northern Trust first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $69M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Northern Trust reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Northern Trust sold 2,328,671 Immunogen Inc shares in Q1 2024, an estimated $69M.
  • Northern Trust first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • Northern Trust's Immunogen Inc position peaked at $69M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Northern Trust's 13F filing for Q1 2024, filed 14 May 2024.